Hereditary hemorrhagic telangiectasia
Clinical trials for Hereditary hemorrhagic telangiectasia explained in plain language.
Never miss a new study
Get alerted when new Hereditary hemorrhagic telangiectasia trials appear
Sign up with your email to follow new studies for Hereditary hemorrhagic telangiectasia, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
A pill to stop the bleeding? new hope for HHT nosebleeds
Disease control Recruiting nowThis phase 3 trial tests whether an experimental oral drug called engasertib can reduce the number of nosebleeds in adults with moderate to severe hereditary hemorrhagic telangiectasia (HHT), a genetic condition that causes abnormal blood vessels and frequent bleeding. About 240 …
Matched conditions: HEREDITARY HEMORRHAGIC TELANGIECTASIA
Phase 3 • Sponsor: Vaderis Therapeutics AG • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New antibody aims to tame rare bleeding disorder
Disease control Recruiting nowThis early-phase trial tests an experimental antibody called DIAG723 in 93 adults with hereditary hemorrhagic telangiectasia (HHT), a condition that causes abnormal blood vessels and frequent nosebleeds. The study will check if the drug is safe and how the body processes it, with…
Matched conditions: HEREDITARY HEMORRHAGIC TELANGIECTASIA
Phase 1/2 • Sponsor: Diagonal Therapeutics, Inc. • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New drug aims to stop nosebleeds in rare blood vessel disorder
Disease control Recruiting nowThis study tests an experimental drug called ATV-1601 in people with moderate to severe HHT, a condition that causes frequent nosebleeds and anemia. The trial has two parts: first, participants receive either the drug or a placebo to check safety and effectiveness; then, all elig…
Matched conditions: HEREDITARY HEMORRHAGIC TELANGIECTASIA
Phase 1/2 • Sponsor: Atavistik Bio, Inc • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Blood thinners in HHT: a risky balancing act under the microscope
Disease control Recruiting nowThis study follows 100 adults with hereditary hemorrhagic telangiectasia (HHT) who start taking blood thinners (anticoagulants or antiplatelets). Researchers compare the three months before treatment to the first three months on treatment, tracking bleeding events, iron levels, a…
Matched conditions: HEREDITARY HEMORRHAGIC TELANGIECTASIA
Sponsor: University Hospital, Clermont-Ferrand • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Donated tissue could reveal how HHT blood vessel tangles form
Knowledge-focused Recruiting nowResearchers at University Hospital Essen are studying donated tissue from people with hereditary hemorrhagic telangiectasia (HHT), a genetic condition that causes abnormal blood vessel tangles called telangiectasias. The study compares tissue with and without these malformations,…
Matched conditions: HEREDITARY HEMORRHAGIC TELANGIECTASIA
Sponsor: University Hospital, Essen • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Massive HHT registry aims to unlock secrets of rare bleeding disorder
Knowledge-focused Recruiting nowThis study creates a large registry of people diagnosed with hereditary hemorrhagic telangiectasia (HHT), a condition causing abnormal blood vessels and bleeding. Researchers will collect medical records and annual health updates for up to 10 years to understand how the disease c…
Matched conditions: HEREDITARY HEMORRHAGIC TELANGIECTASIA
Sponsor: Cure HHT • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC